Insider trades
Krishna Vaddi, CEO of Prelude Therapeutics PRLD, has filed 14 purchases and 0 sales on the open market. The latest trade was on 02/04.
Krishna Vaddi
CEO
- Company
- Prelude Therapeutics PRLD
- First filing
- 23/02/09
- Trades
- 18 trades
- Buys / sales
- 14 / 0
- 12-month net buying
- No record
- Last trade
- 02/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/03/25 | 25/03/27 | 675,000 sh | $0.69 | $465,750 | +51.0% | |
PRLD | Open-market buy | 25/03/20–25/03/21 | 25/03/24 | 20,416 sh2 trades | $0.73avg. | $14,903.68 | +1.6% |
PRLD | Open-market buy | 25/03/14–25/03/17 | 25/03/18 | 39,105 sh2 trades | $0.75avg. | $29,328.75 | +3.1% |
PRLD | Open-market buy | 25/03/12–25/03/13 | 25/03/14 | 97,500 sh2 trades | $0.72avg. | $69,725 | +8.4% |
| Open-market buy | 24/12/31 | 25/01/03 | 5,000 sh | $1.21 | $6,050 | +3.6% | |
| Open-market buy | 24/12/30 | 25/01/02 | 10,000 sh | $1.20 | $12,000 | +7.8% | |
PRLD | Open-market buy | 24/12/18–24/12/19 | 24/12/20 | 106,888 sh2 trades | $0.93avg. | $99,130.32 | No record |
PRLD | Open-market buy | 23/05/24–23/05/25 | 23/05/26 | 1,900 sh2 trades | $5.15avg. | $9,789 | +0.2% |
| Open-market buy | 23/05/23 | 23/05/25 | 11,856 sh | $5.63 | $66,749.28 | +1.1% |